The Hypertriglyceridemia Market was valued at USD 3.5 billion in 2024 and is projected to reach USD 6.8 billion by 2034, registering a CAGR of 7.0%. This growth trajectory is underpinned by an increasing prevalence of hypertriglyceridemia, driven by lifestyle changes, dietary habits, and the rising incidence of metabolic disorders. The demand for effective treatment options, including...